Surprisingly, TRAF1 transgenic (TG-TRAF1) mice showed enlarged stroke lesions while TRAF1-deficient (TRAF1-KO) mice showed significant lesion reduction (Lu et al., 2013). This evidence concerns the gene TRAF1 and Stroke.